Arteris, Inc. AIP

Synopsys (SNPS) stock could climb about 25% before it reaches a level that has turned it back three times. It could fall about 5% before the floor it sits on gives way. On paper, that is a generous trade on a maker of chip-design software. The catch is the floor itself, which has a poor record over the past two years.

Synopsys (SNPS) sells the electronic design automation software and design IP that chipmakers use to build new chips. Its stock has lost 16.3% over the past year, while the S&P 500 gained 18.5%. A Needham analyst said on the fiscal Q3 2026 earnings call that the question investors keep asking is whether AI could learn to design chips without those tools. The biggest risk is not a sudden break. It is that Ansys revenue could hide the threat inside the headline totals while it builds.

Two years of Synopsys (SNPS) earnings calls show management changing what it explains. The company used to open on problems, some outside its control and some its own. The August 2026 call is built around a joint product with Ansys, agentic AI, and a new way to charge for its design IP. Most of that switch is earned, but parts of it are still a promise.

Synopsys (SNPS) sells the design software and the interface IP that chip makers need to get AI silicon built, and its stock has still gone backwards over the past year. At about $370 the shares sit at their 52-week low. Reported margins have fallen sharply over the past year. Free cash flow tells a different story, and the gap between cash and reported profit is the case worth arguing here.

Arteris has seen its share price move sharply in recent years, and after a pullback in recent weeks the key issue is whether the current US$20.41 level can be supported by the revenue the business is generating. With the focus firmly on chip design tools for complex multi-die architectures, the question for you is how much sales performance can reasonably underpin that kind of ride. Over the past 3 years the stock has gained 213.0%, which makes the gap between the share price story and the...

Earlier this year, Arteris, Inc. expanded its multi-die portfolio with the FlexGen Multi-Die product, designed to help semiconductor companies move from monolithic system-on-chip designs to chiplet-based architectures for AI, high-performance computing, and consumer electronics. The launch aims to tackle one of the hardest problems in multi-die systems, efficient, secure data movement across multiple chips, while giving engineering teams more automation and architectural flexibility as...

Expanded solution includes new FlexGen Multi-Die product to address the challenge of efficient data movement for an industry that is shifting to multi-die architectures, while preserving quality of service and architectural flexibility across chip boundariesCAMPBELL, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced an expansion of its multi-die portfolio that helps sem

Synopsys (SNPS) trades near $400, and the options market has already drawn the boundaries it expects the stock to hold over roughly the next twelve months: about $251 at the floor and about $630 at the ceiling. That is a very wide year to be holding a single name. What matters is that for this stock, a range that wide is ordinary.

CAMPBELL, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the company’s board of directors has granted equity awards to Saurabh Sinha, the company’s Chief Financial Officer, as inducement awards material to Mr. Sinha’s acceptance of employment with the company under the company’s 2022 Employment Inducement Incentive Plan. The grants were made in accordance with Nasdaq

Synopsys (SNPS) trades about 26% below its 52-week high after falling about 34% over the past year. You can be paid now to agree to buy it well below today's price, and you keep that payment either way. The catch is that you must want the business. One analyst says investors constantly ask whether AI could disrupt the kind of software Synopsys sells, and that a school of thought asks whether AI could design chips end to end without it.

The chip design giant is pushing into a new, more lucrative business model, and while its stock has a strong record of bouncing back, there's a catch you can't ignore.

Synopsys (SNPS) booked revenue of $2.477 billion in fiscal Q3 2026, up about 42% year over year, and the shares have still lost about 30% over the past twelve months. Look past that headline at the line underneath it: EDA grew 8.5%. That single-digit number is the pace of the design tools business Synopsys had before the Ansys deal.

The chip-design software maker wants to add a royalty on the custom AI chips its biggest customers build, on top of the interface IP license fees it already charges them.

A critical piece of the AI supply chain has seen its stock slide back to a familiar floor, forcing investors to ask if history's powerful rebound rhyme is about to repeat.

The options market is charging less volatility than the stock has actually delivered over the past year, which makes the width of the priced band the part a holder should read.

Arteris Inc (AIP) raises full-year guidance amid strong demand for AI and automotive chip design technology.